What is the Impact Factor of Acta Pharmacologica Sinica?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Acta Pharmacologica Sinica is 10.4, ranking in quartile Q1 of Web of Science (SCIE).

Is Acta Pharmacologica Sinica indexed in Web of Science or Scopus?

Yes, Acta Pharmacologica Sinica is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 2.691 (Q1) and an H-index of 134.

Who publishes Acta Pharmacologica Sinica and what is the Article Processing Charge (APC)?

Acta Pharmacologica Sinica is published by Nature Publishing Group. The estimated Article Processing Charge (APC) is approximately $3,784 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Acta Pharmacologica Sinica?

The official ISO-4 abbreviation of Acta Pharmacologica Sinica is "ACTA PHARMACOL. SIN" with common acronym "aphs". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #862Top JournalHybridDomestic Journal

Acta Pharmacologica Sinica

Acronym:aphs

•

Abbreviation (ISO):ACTA PHARMACOL. SIN

•

Identifier (ISSN):1671-4083(Print)/1745-7254(Online)

•

Publisher:Nature Publishing Group

Official Website Submission Portal Compare

Clarivate IF (2026)

10.4↑ +2

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Acta Pharmacologica Sinica

WoS Q1

Annual Impact Factor Metric

Current (2026):10.4

Scopus SJR & RankScopus Q1

2.691

#862

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

134

134 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate1.4%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

243articles/year

11.02% Gold OA•79.68% Original Research

Aims & Scope

APS (Acta Pharmacologica Sinica) encourages submissions from all areas of pharmacology and the life sciences. Topics of particular interest include, but are not limited to, anticancer pharmacology, cardiovascular and pulmonary pharmacology, clinical pharmacology, drug discovery, gastrointestinal and hepatic pharmacology, genitourinary, renal and endocrine pharmacology, immunopharmacology and inflammation, molecular and cellular pharmacology, neuropharmacology, pharmaceutics and pharmacokinetics.

Topics Covered (Recognized by AI)

Biology98.3%Medicine96.3%Chemistry92.7%Biochemistry88.6%Internal medicine88.3%Genetics86.5%Endocrinology56.5%Pharmacology44.7%Organic chemistry42.6%Gene41.4%Cell biology40.1%Physics34.7%Immunology33%Pathology31.9%Receptor31.8%Psychology31.6%In vitro26.7%Nuclear magnetic resonance26.4%Apoptosis26.2%Enzyme24.6%Molecular biology22.3%Cell culture21.1%Neuroscience20.8%

Primary Research Areas

Medicine Chemistry Multidisciplinary

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

CHEMISTRY, MULTIDISCIPLINARY

Rank37/250

IndexSCIE

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank16/356

IndexSCIE

JCISCIE2026

CHEMISTRY, MULTIDISCIPLINARY

Rank20/251

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank18/356

IndexSCIE

Category	Index	Rank	Quartile
CHEMISTRY, MULTIDISCIPLINARY	JCRSCIE	37/250	Q1
PHARMACOLOGY & PHARMACY	JCRSCIE	16/356	Q1
CHEMISTRY, MULTIDISCIPLINARY	JCISCIE	20/251	Q1
PHARMACOLOGY & PHARMACY	JCISCIE	18/356	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF10.4

Articles / Year232

Total Citations143

2025

IF8.4

Articles / Year257

Total Citations1,563

2024

IF6.9

Articles / Year232

Total Citations4,141

2023

IF8.2

Articles / Year167

Total Citations5,018

2022

IF7.169

Articles / Year202

Total Citations7,677

Year	Impact Factor	Articles / Year	Total Citations
2026	10.4	232	143
2025	8.4	257	1,563
2024	6.9	232	4,141
2023	8.2	167	5,018
2022	7.169	202	7,677
2021	6.15	258	10,634
2020	5.064	248	15,695
2019	4.01	132	6,324
2018	3.562	224	13,145
2017	—	205	13,216
2016	—	241	7,972
2015	—	153	6,618

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #862Scopus Q1SCImago Profile

Scopus Coverage:1980-2026

•

Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q1

2.691

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

10.94

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,784 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations7,198

3-Year Documents676

Citable Documents668

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1

PharmacologyQ1

Pharmacology (medical)Q1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 1.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

1区 (Zone 1)Medicine

Minor Category (Specific Field):

1区CHEMISTRY, MULTIDISCIPLINARY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Acta Pharmacologica Sinica (acronym: aphs, abbr: ACTA PHARMACOL. SIN, ISSN: 1671-4083) is a peer-reviewed international scholarly journal in the field of Medicine, published by Nature Publishing Group in China since 1980. The periodical holds a Journal Impact Factor (JIF) of 10.4, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 2.691 (Q1), an H-index of 134.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 243 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,784 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.